![]() |
市場調查報告書
商品編碼
1734876
2032 年眼瞼磨砂膏市場預測:按產品類型、類型、配方、分銷管道、應用、最終用戶和地區進行的全球分析Eyelid Scrub Market Forecasts to 2032 - Global Analysis By Product Type (Pre-Moistened Scrubs, Spray Scrubs and Dry Pad Scrubs), Type, Formulation, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球眼瞼磨砂膏市場預計在 2025 年達到 37 億美元,到 2032 年將達到 68 億美元,預測期內的複合年成長率為 9.2%。
眼瞼磨砂膏是用於去除眼瞼和睫毛根部污垢、細菌和多餘油脂的清潔液或濕紙巾。它們有助於保持眼部衛生,預防發炎以及諸如眼瞼炎和乾眼症等疾病。眼瞼磨砂膏通常含有溫和的界面活性劑、抗菌劑和舒緩成分,可促進眼部舒適並減輕發炎。定期使用眼瞼磨砂膏可以去除引起不適和感染的污染物,從而促進整體眼部健康,確保視力更清晰,眼瞼組織更健康。
根據美國美國生物技術資訊中心(NCBI)公佈的數據,據報導,美國乾眼症的患病人數為2,750萬人,英國為2,260萬人,德國為1,800萬人,澳洲為240萬人,印度為4.572億人。
眼瞼炎和乾眼症的盛行率不斷上升
隨著這些眼科疾病在各個人群中日益普遍,對有效的家庭治療和預防性衛生習慣的需求也在穩步成長。患有眼瞼炎和併發症並伴有不適和潛在併發症的人們正在積極尋求眼瞼磨砂膏等便捷的解決方案來控制症狀並保持眼部健康。盛行率的上升,加上人們對這些疾病的認知不斷提高,直接促進了眼瞼清潔產品市場的擴張。
消費者知識有限
由於消費者對眼瞼清潔的重要性以及這些產品帶來的實際益處缺乏了解,市場發展受到阻礙。許多消費者可能並未充分意識到定期清洗眼瞼在預防和控制眼瞼炎、乾眼症等疾病方面所扮演的角色。這種認知不足可能會導致眼瞼磨砂膏的普及率較低,市場擴張緩慢,因為消費者可能不會優先購買眼瞼磨砂膏,而是優先購買普通的洗面乳或其他護膚品。
天然成分和低過敏性配方的創新
隨著消費者越來越偏好選擇更溫和、更天然的成分,能夠提供有效且不含刺激性化學物質和潛在過敏原的眼瞼磨砂膏的製造商將擁有競爭優勢。這一趨勢對於皮膚或眼睛敏感的人尤其重要,因為他們可能一直以來都不願意使用眼瞼清潔產品。滿足消費者對較溫和、親膚的產品日益成長的需求,可以幫助企業擴大市場覆蓋範圍,並提升消費者信任度。
與現有護膚和製藥公司的激烈競爭
這些規模較大的公司通常擁有品牌知名度、廣泛的分銷網路和雄厚的行銷預算,這使得眼瞼磨砂膏領域的小型公司或新參與企業難以獲得市場佔有率。消費者已經有了自己偏好的護膚習慣,或依賴醫療保健專業人士推薦的處方藥或非處方藥,因此他們可能會忽略專注於眼瞼衛生的產品。
新冠疫情對眼瞼清潔產品市場產生了多方面的影響。一方面,人們對個人衛生和健康意識的提升可能間接提高了人們對眼部護理習慣的關注,並刺激了眼瞼清潔產品的需求。另一方面,供應鏈中斷、經濟不確定時期消費者在非必需品上的支出減少以及醫療保健重點的轉變,都可能對市場成長構成挑戰。
預計在預測期內,預濕磨砂膏市場將佔據最大佔有率
噴霧式眼部磨砂膏預計將在預測期內佔據最大的市場佔有率,因為噴霧式眼部磨砂膏的便利性和易用性使其成為日常眼瞼清潔的熱門選擇。其便攜性和預先計量的配方深受尋求快速有效清潔解決方案的忙碌消費者的青睞。
預計在預測期內,有機/天然部分將以最高的複合年成長率成長。
預計有機/天然產品類別將在預測期內實現最高成長率,這得益於消費者對天然和植物來源成分產品的日益偏好,這主要源於消費者對潛在皮膚敏感問題的擔憂以及對更健康生活方式的普遍追求。隨著消費者積極尋求更清潔、更永續的個人護理選擇,對溫和有效的有機天然眼瞼磨砂膏的需求預計將大幅成長。
預計亞太地區將在預測期內佔據最大的市場佔有率,這得益於其人口眾多、人們對眼部健康問題的認知不斷提高、可支配收入不斷增加以及醫療保健和個人保健產品供應的日益增加。此外,亞太地區部分地區的環境因素和生活方式的改變導致眼科疾病盛行率上升,這也推動了市場的成長。
在預測期內,北美預計將實現最高的複合年成長率,這得益於該地區對醫療保健和個人健康的日益重視、消費者對眼部健康的高度關注、先進的醫療基礎設施和創新產品的普及。此外,北美地區乾眼症和眼瞼炎的盛行率不斷上升,以及積極主動的治療措施,預計將顯著促進市場的快速擴張。
According to Stratistics MRC, the Global Eyelid Scrub Market is accounted for $3.7 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 9.2% during the forecast period. Eyelid scrub is a cleansing solution or wipe designed to remove debris, bacteria, and excess oils from the eyelids and lash margins. It helps maintain ocular hygiene, preventing irritation and conditions such as blepharitis or dry eye syndrome. Typically formulated with gentle surfactants, antimicrobial agents, or soothing ingredients, eyelid scrubs promote eye comfort and reduce inflammation. Regular use supports overall eye health by eliminating contaminants that can contribute to discomfort or infection, ensuring clearer vision and healthier eyelid tissue.
According to data published by the National Centers for Biotechnology Information (NCBI), it was reported that the prevalence of dry eye disease is 27.5 million in the U.S., 22.6 million in the U.K., 18.0 million in Germany, 2.4 million in Australia, and 457.2 million in India.
Rising prevalence of blepharitis and dry eye syndrome
As these ocular conditions become more prevalent across various demographics, the demand for effective at-home treatments and preventative hygiene practices is steadily increasing. Individuals experiencing the discomfort and potential complications associated with blepharitis and dry eye are actively seeking accessible solutions like eyelid scrubs to manage their symptoms and maintain ocular health. This growing patient pool, coupled with increased awareness of these conditions, directly contributes to the expanding market for eyelid cleansing products.
Limited consumer knowledge
The limited understanding among consumers regarding the importance of eyelid hygiene and the specific benefits offered by these products hamper the market. Many individuals may not be fully aware of the role that regular eyelid cleansing plays in preventing and managing conditions like blepharitis and dry eye. This lack of awareness can result in lower adoption rates and a slower market expansion as consumers might not prioritize the purchase of dedicated eyelid scrubs over general facial cleansers or other skincare products.
Innovation in natural and hypoallergenic formulations
As consumer preferences increasingly lean towards gentler and more natural ingredients, manufacturers who can offer effective eyelid scrubs free from harsh chemicals and potential allergens stand to gain a competitive edge. This trend is especially relevant for individuals with sensitive skin or eyes, who may have previously been hesitant to use conventional eyelid cleansing products. By catering to this growing demand for milder and more skin-friendly options, companies can expand their market reach and foster greater consumer trust.
Intense competition from established skincare and pharmaceutical companies
These large corporations often possess significant brand recognition, extensive distribution networks, and substantial marketing budgets, making it challenging for smaller or newer entrants in the eyelid scrub segment to gain market share. Consumers may already have preferred skincare routines or rely on prescription or over-the-counter medications recommended by healthcare professionals, potentially overlooking specialized eyelid hygiene products.
The COVID-19 pandemic had a multifaceted impact on the Eyelid Scrub market. On one hand, increased focus on personal hygiene and health awareness may have indirectly led to greater attention on eye care routines, potentially boosting demand for eyelid cleansing products. Conversely, disruptions in supply chains, reduced consumer spending on non-essential items during periods of economic uncertainty, and shifts in healthcare priorities could have presented challenges for market growth.
The pre-moistened scrubs segment is expected to be the largest during the forecast period
The pre-moistened scrubs segment is expected to account for the largest market share during the forecast period attributed to the convenience and ease of use offered by pre-soaked wipes, making them a popular choice for daily eyelid hygiene. Their portability and pre-measured formulation resonate well with busy consumers seeking a quick and effective cleansing solution.
The organic/natural segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the organic/natural segment is predicted to witness the highest growth rate due to rapid growth reflects the increasing consumer preference for products formulated with natural and plant-derived ingredients, driven by concerns about potential skin sensitivities and a general inclination towards healthier lifestyles. The demand for gentle yet effective organic and natural eyelid scrubs is expected to surge as consumers actively seek out cleaner and more sustainable personal care options.
During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to the region's large population base, rising awareness of eye health issues, increasing disposable incomes, and growing accessibility to healthcare and personal care products. Furthermore, environmental factors and lifestyle changes contributing to a higher prevalence of eye conditions in certain parts of Asia Pacific are also likely to fuel market growth.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR driven by a strong emphasis on healthcare and personal wellness, high consumer awareness of eye health, and the presence of advanced healthcare infrastructure and innovative product offerings. Additionally, the increasing prevalence of dry eye disease and blepharitis in North America, coupled with proactive approaches to managing these conditions, is expected to contribute significantly to the market's rapid expansion.
Key players in the market
Some of the key players in Eyelid Scrub Market include Visine, TheraTears, Thea Pharmaceuticals, Systane, Scope Ophthalmics, Optase, OCuSOFT, NovaBay Pharmaceuticals, Lumenis, Johnson & Johnson Vision, Heyedrate, Cliradex, Bruder Healthcare, Blephadex, Bausch + Lomb, Avenova and Akorn Pharmaceuticals.
In April 2025, Lumenis announced the expansion of its FoLix(TM) fractional laser treatment for hair loss into the Canadian market. The product, which is FDA and Health Canada-cleared, was also named 'Best Laser Treatment for Hair Loss' by NewBeauty's 15th Annual Beauty Awards.
In February 2025, Cliradex announced the reformulation of its natural eyelid towelettes to enhance efficacy against Demodex mites, a common cause of blepharitis. The new formulation aims to provide improved relief for patients suffering from ocular irritation.
In January 2025, Heyedrate launched a new eyelid and facial cleanser formulated with organic ingredients to provide relief for dry, itchy eyes and skin conditions like blepharitis and rosacea. The product is designed to be gentle yet effective, catering to individuals with sensitive skin.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.